On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Short and Associates (United States)

InstitutionResearch output, impact & collaborations

Short and Associates (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Short and Associates (United States)?

ScholarIQrecord summary

Short and Associates (United States) is a research organisation in Stamford, US. OpenAlex records 1,990 works and 50,029 citations for it. 505 researchers list it as their most recent affiliation.

How many works does Short and Associates (United States) have?

ScholarIQindexed works

Short and Associates (United States) has 1,990 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Short and Associates (United States) →

How many citations does Short and Associates (United States) have?

ScholarIQcitation count

Short and Associates (United States) has 50,029 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Short and Associates (United States) →

How many researchers are at Short and Associates (United States)?

ScholarIQresearcher count

Short and Associates (United States) has 505 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Short and Associates (United States)?

ScholarIQavg h-index

Short and Associates (United States) has an average h-index of 37 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Short and Associates (United States)?

ScholarIQror

The ROR for Short and Associates (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Short and Associates (United States)?

ScholarIQopenalex

The OpenAlex for Short and Associates (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Short and Associates (United States)?

ScholarIQtop researchers by citations

Steven P. Marso · Diabetes Treatment and Management

117 works23,329 citations

What are the most-cited papers on Short and Associates (United States)?

ScholarIQmost cited works

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen, Peter Lommer Kristensen, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock, Neil R Poulter, Lasse Steen Ravn, William M. Steinberg, Mette Stockner, Bernard Zinman, Richard M. Bergenstal, John B. Buse

New England Journal of Medicine. 20167,491 CitationsOPEN ACCESS

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Steven P. Marso, Stephen C. Bain, Agostino Consoli, Freddy G. Eliaschewitz, Esteban Jódar, Lawrence A. Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark Warren, Vincent Woo, Oluf H. Hansen, Anders G. Holst, Jonas Pettersson, Tina Vilsbøll

New England Journal of Medicine. 20166,751 CitationsOPEN ACCESS

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz, Vivian P. Thompson, Yuliya Lokhnygina, John B. Buse, Juliana C.N. Chan, Jasmine Choi, Stephanie M. Gustavson, Nayyar Iqbal, Aldo P. Maggioni, Steven P. Marso, Peter Öhman, Neha J. Pagidipati, Neil R Poulter, Ambady Ramachandran, Bernard Zinman, Adrian F. Hernandez

New England Journal of Medicine. 20172,171 CitationsOPEN ACCESS

Liraglutide and Renal Outcomes in Type 2 Diabetes

Johannes F.E. Mann, David D. Ørsted, Kirstine Brown‐Frandsen, Steven P. Marso, Neil R Poulter, Søren Rasmussen, Karen Tornøe, Bernard Zinman, John B. Buse

New England Journal of Medicine. 20171,244 CitationsOPEN ACCESS

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, Poul-Martin Haahr, Martin Lange, Kirstine Brown‐Frandsen, Alan C. Moses, Simon Skibsted, Kajsa Kvist, John B. Buse

New England Journal of Medicine. 2017570 CitationsOPEN ACCESS

How much of the research on Short and Associates (United States) is open access?

ScholarIQopen access share

75%OPEN ACCESS

Gold

Green

13%

Hybrid

Bronze

63%

Closed

25%